JDD Corner

JDD Buzz | Impact of Weight Loss on Soft Tissue
Ozempic face dermatology treatmentFrom news articles to social media, “Ozempic face” is commonly used to describe facial changes that accompany rapid weight loss from GLP-1 receptor agonists. A gaunt, sunken, and aged appearance is commonly attributed to Ozempic and other GLP-1s. However, bariatric surgery and dietary changes can also lead to skin laxity and loss of facial volume. Irrespective of the weight loss method, patien …
Ozempic face dermatology treatment
JDD Buzz Series | Patient Perspectives on Scalp Biopsies for CCCA
A graphic featuring the text 'PATIENT PERSPECTIVES ON SCALP BIOPSIES FOR CCCA' over a microphotograph of a scalp biopsy sample showing inflammatory cells around a hair follicle.Scalp biopsies are an important tool in diagnosing central centrifugal cicatricial alopecia (CCCA), especially in atypical presentations where making an accurate diagnosis through other means is challenging. Even though a biopsy-confirmed diagnosis could lead to hair-saving treatment, hair loss patients sometimes balk at the recommendation to biopsy. The authors of a brief communication published …
A graphic featuring the text 'PATIENT PERSPECTIVES ON SCALP BIOPSIES FOR CCCA' over a microphotograph of a scalp biopsy sample showing inflammatory cells around a hair follicle.
JDD April 2026 Highlights
Journal of Drugs in Dermatology April 2026 Issue Highlights Welcome to the April edition the JDD Highlights! Each month, we dive into the Journal of Drugs in Dermatology to bring you the most impactful research and clinical updates selected by the editor. This month’s selection reflects the rapidly evolving landscape of modern dermatology. From the diagnostic precision of Artificial Intelligence in nail disorders to the "cosmetic elegance" of seborrhe …
Journal of Drugs in Dermatology April 2026 Issue Highlights
JDD Buzz Series | Topical Nonsteroidal Therapies for Atopic Dermatitis
Topical Nonsteroidal Therapies for Atopic DermatitisTopical corticosteroids have been a mainstay of frontline therapy for atopic dermatitis (AD) for more than half a century. Now therapeutic advances are challenging that standard of care. Nonsteroidal topicals -- topical JAK inhibitors, aryl hydrocarbon receptor agonists, and PDE-4 inhibitors -- are expanding pathways of addressing the signs and symptoms of AD.  An article in the March Journal …
Topical Nonsteroidal Therapies for Atopic Dermatitis
JDD March 2026 Issue Highlights
JDD March Editor’s PicksThe March issue of the Journal of Drugs in Dermatology (JDD) gathers a timely, practice‑oriented collection of studies and reports selected as this month’s Editor’s Picks — spanning potential disease‑modifying implications of antiviral therapy, long‑term biologic data, evolving topical and systemic options for inflammatory skin disease, and a range of hair‑ and nail‑focused investi …
JDD March Editor’s Picks